[1]
B. Radwan and İ. İ. Boşgelmez, “The Safety of Chelators for Iron Overload in Sickle Cell Disease: A Brief Systematic Review”, Acta Medica, vol. 50, no. 3, pp. 50–60, Sep. 2019.